MIR1205: A Potential Drug Target and Biomarker (G100302161)
MIR1205: A Potential Drug Target and Biomarker
MIR1205 is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the MIR gene family, which encodes for non-coding RNA-binding proteins. One of the functions of MIR1205 is to interact with the protein known as sphingomyelin, which is a component of cell membranes. This interaction between MIR1205 and sphingomyelin has been identified as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
MIR1205 has also been identified as a potential biomarker for several diseases. For example, MIR1205 has been shown to be upregulated in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder that is characterized by the progressive loss of brain cells. This increase in MIR1205 expression has been associated with an increased risk of developing Alzheimer's disease. Therefore, MIR1205 may be a useful biomarker for the diagnosis and treatment of this disorder.
In addition to its potential drug-target and biomarker properties, MIR1205 has also been shown to have several other biological functions. For example, MIR1205 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and survival. It has also been shown to interact with several other proteins, including the protein known as NF-kappa-B, which is involved in the regulation of inflammation and immune responses.
The identification of MIR1205 as a potential drug target and biomarker has led to a greater understanding of its underlying biology and potential clinical applications. MIR1205 has also sparked interest in the use of small molecules and other natural compounds as potential therapeutic agents to target this protein. For example, several studies have shown that inhibitors of MIR1205 have been effective in reducing the growth of cancer cells, and that these inhibitors may be useful as a treatment for cancer.
In conclusion, MIR1205 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its interaction with sphingomyelin and its role in the regulation of cellular processes make it an attractive target for small molecules and other therapeutic agents. Further research is needed to fully understand the biology of MIR1205 and its potential clinical applications.
Protein Name: MicroRNA 1205
More Common Targets
MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296
